+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody

A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody

Bone Marrow Transplantation 10(6): 485-489

Previous studies have shown that the lectin peanut agglutinin (PNA) binds bone marrow plasma cells in the majority of patients with myeloma and does not bind to normal haemopoietic progenitors. This lectin has been used in combination with anti-CD19 monoclonal antibody (moAb) in a system for purging myeloma bone marrow. This has now been scaled up for application to ex vivo treatment of large volumes of bone marrow suitable for autologous bone marrow transplantation. Four bone marrow harvests from patients with myeloma containing 9.5 +/- 4.9% plasma cells were depleted of erythrocytes and mature granulocytes by Ficoll separation using the Haemonetics V50 cell separator. The mononuclear fraction was then purged with magnetic beads coated with PNA and anti-CD19 moAb. The system proved highly efficient with removal of all detectable plasma cells and CD19+ cells. Average mononuclear cell recovery following purging was 71% of the concentrated marrow with 78% yield of CFU-GM. Normal progenitor recovery related to patients' weight is predicted to be adequate for haemopoietic reconstitution following ablative chemoradiotherapy. This system is therefore feasible for large-scale clinical purging.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 008045165

Download citation: RISBibTeXText

PMID: 1490198

Related references

Peanut agglutinin in combination with CD19 monoclonal antibody has potential as a purging agent in myeloma. Experimental Hematology 19(8): 833-837, 1991

The synthesis of a peanut agglutinin-ricin A chain conjugate: potential as an in vitro purging agent for autologous bone marrow in multiple myeloma. Experimental Hematology 23(13): 1347-1352, 1995

Combined lectin/monoclonal antibody purging of bone marrow for use in conjunction with autologous bone marrow transplantation in the treatment of multiple myeloma. Methods in Molecular Medicine 9: 351-361, 1998

Treatment of human b cell lymphoma with anti cd19 monoclonal antibody and with a combination of anti cd19 and il 2. Groopman, J E , D W Golde And C H Evans (Ed ) Ucla (University Of California-Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 100 Mechanisms Of Action And Therapeutic Applications Of Biologicals in Cancer And Immune Deficiency Disorders; Hoffman-La Roche-Smith Kline And French-Ucla Symposium, Keystone, Colorado, Usa, April 23-30, 1988 Xix+406p Alan R Liss, Inc : New York, New York, Usa Illus 293-304, 1989

Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide. Progress in Clinical and Biological Research 333: 311-319, 1990

The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation. Molecular Biotechnology 11(2): 181-194, 1999

The Use of Soybean Agglutinin (SBA) for Bone Marrow (BM) Purging and Hematopoietic Progenitor Cell Enrichment in Clinical Bone Marrow Transplantation. Methods in Molecular Medicine 9: 329-350, 1998

Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement. Iarc Scientific Publications 1985(60): 435-440, 1985

Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu. Blood 112(4): 1329-1337, 2007

Large scale purging of myeloma bone marrow using pna and cd19 coated magnetic beads. Bone Marrow Transplantation 5(SUPPL 2): 93, 1990

Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-Sca-1 monoclonal antibody and wheat germ agglutinin. Blood 84(3): 753-763, 1994

A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial. International Journal of Hematology 69(1): 27-35, 2000

Characterization of a new anti-CD45RA monoclonal antibody, 6G7, and its experimental application in ex vivo bone marrow purging. Blood 84(10 SUPPL 1): 732A, 1994

Characterization and purification of osteogenic stem cells from murine bone marrow by two color cell sorting using anti-SCA-1 monoclonal antibody and wheat germ agglutinin. Journal of Cellular Biochemistry Supplement 0(18B): 192, 1994

Direct monoclonal antibody rosetting technique dart an effective method for bone marrow purging. Bone Marrow Transplantation 2(SUPPL 2): 139, 1987